ADHD-Match: Specialized Practitioner Directory for ADHD and Executive Dysfunction
Individuals with ADHD waste time and money on general psychotherapy because practitioners frequently misunderstand executive dysfunction, misattribute symptoms to anxiety, and fail to provide actionable neurological or medical guidance.
Is the problem real?
Individuals with ADHD attempt to treat or fix a neurodevelopmental condition using general psychotherapy instead of accepting it or utilizing medication, resulting in frustration, wasted money, and unmanaged functional impairments.
EVIDENCE
I Spent Years Trying to Psychologize My
I Spent Years Trying to Psychologize My
Who feels this pain?
TARGET USERS
Professionals and students diagnosed with or seeking help for ADHD who face misdiagnoses and dead-end talk therapy.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Multiple reports of general psychologists failing to understand ADHD root causes and misattributing symptoms to anxiety.
Exclusively vetted for true ADHD competence, cutting out generalists who waste patient time and misdiagnose core symptoms.
A curated directory and screening platform matching ADHD patients specifically with validated psychiatric practitioners, medication management specialists, and executive function coaches who deeply understand neurodivergence.
How does it make money?
MONETIZATION
Model
Patients already spend hundreds or thousands on ineffective general therapy out-of-pocket, creating high demand for targeted matching, while practitioners value targeted inbound patient acquisition.
How do you ship it?
MVP PLAN
“Connect with verified ADHD specialists in 3 clicks.”
A curated directory and screening platform matching ADHD patients specifically with validated psychiatric practitioners, medication management specialists, and executive function coaches who deeply understand neurodivergence.
Core Features
Weekly Roadmap
- •Build practitioner profile schema
- •Create filter logic for ADHD specialization and medication management
- •Design intake questionnaire UI
- •Implement symptom-to-specialist matching algorithm
- •Build practitioner onboarding and profile claim flow
- •Set up secure contact and booking handoff
- •Recruit initial cohort of ADHD specialists and coaches
- •Test intake match accuracy with beta users
- •Implement basic analytics and error tracking
- •Launch on r/ADHD and related spaces
- •Collect feedback from initial patient matches
- •Refine practitioner verification criteria
Target online neurodivergent communities, Reddit (r/ADHD), and X communities focused on neurodiversity and mental health advocacy.
RISKS & ASSUMPTIONS
Top Risks
Attracting verified ADHD specialists before building a large patient base is challenging.
Patients may still encounter providers who claim ADHD expertise but rely on outdated generalist methods.
Reaching users who are overwhelmed and frustrated by prior healthcare failures requires high trust and empathy.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for Marketplace founders
It sits at the intersection of "healthcare", "marketplace", "mental-health", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. Marketplace opportunities require credible answers to the chicken-and-egg problem on day one. The founder evaluating this should look hard at whether one side of the marketplace already has a forced reason to participate (existing community, regulatory requirement, supply scarcity) before assuming the other side will follow. The MonetScope pipeline surfaces this category alongside other marketplace signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "ADHD-Match: Specialized Practitioner Directory for ADHD and Executive Dysfunction" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for healthcare?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most marketplace opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.